CAS 55981-09-4: Nitazoxanide
Formula:C12H9N3O5S
InChI:InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)
InChI key:InChIKey=YQNQNVDNTFHQSW-UHFFFAOYSA-N
SMILES:C(NC=1SC(N(=O)=O)=CN1)(=O)C2=C(OC(C)=O)C=CC=C2
Synonyms:- 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide
- 2-[(5-Nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
- Alinia
- Brn 1225475
- Cryptaz
- Daxon
- Dexidex
- Drg 0242
- Kidonax
- Mitafar
- N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)
- See more synonyms
Sort by
Found 15 products.
Nitazoxanide
CAS:Nitazoxanide (NSC-697855) is a synthetic benzamide antiprotozoal; it disrupts pyruvate electron transfer reactions.Formula:C12H9N3O5SPurity:97.20% - 99.53%Color and Shape:SolidMolecular weight:307.28Ref: TM-T1546
1g750.00€5mg35.00€10mg51.00€25mg90.00€50mg139.00€100mg207.00€200mg311.00€500mg520.00€1mL*10mM (DMSO)55.00€Nitazoxanide
CAS:Controlled ProductApplications An anthelmintic (cestodes), antiprotozoal (cryptosporidium). Kills Mycobacterium tuberculosis. References Cavier, R., et al.: Eur. J. Med. Chem.-Chim. Ther., 13, 539 (1978), Dubreuil, L., et al.: Antimicrob. Ag. Chemother., 40, 2266 (1996), Stockis, A., et al.: Int. J. Clin. Pharmacol. Ther., 34, 349 (1996), Nathan, C., et al.: J. Med. Chem. 52, 5789 (2009); de Carvalho et. al., J. Med. Chem., 52, 5789 (2009)Formula:C12H9N3O5SColor and Shape:Light Yellow CrystallineMolecular weight:307.28Nitazoxanide
CAS:Purity:95.0%Color and Shape:Liquid, Crystalline Powder or PowderMolecular weight:307.2799987792969Nitazoxanide
CAS:Formula:C12H9N3O5SPurity:>98.0%(T)(HPLC)Color and Shape:White to Orange to Green powder to crystalMolecular weight:307.28Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-
CAS:Formula:C12H9N3O5SPurity:98%Color and Shape:SolidMolecular weight:307.28196Nitazoxanide
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C12H9N3O5SColor and Shape:Light Yellow Yellow PowderMolecular weight:307.02629Nitazoxanide - Bio-X ™
CAS:Nitazoxanide acts as a noncompetitive inhibitor of the pyruvate: ferredoxin/flavodoxin oxidoreductases of various microorganism with Ki values between 2 and 10 μM. Nitazoxanide is clinically relevant for its broad-spectrum action to reduce the growth of bacteria, various parasites, and especially for its efficacy against the pathogen Helicobacter pylori. Nitazoxanide also has been shown to be effective in treating inflammatory bowel disease and acute enteritis caused by bacteria. In 2021, nitazoxanide was tested for the treatment of COVID-19 patients with mild symptoms due to its broad antiviral action. Nitazoxanide is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formula:C12H9N3O5SPurity:Min. 90 Area-%Color and Shape:PowderMolecular weight:307.28 g/molNitazoxanide
CAS:Nitazoxanide is a prodrug that is converted to the active form, nitazoxanide triacetate, in the stomach. It inhibits the growth of infectious agents by preventing their synthesis of DNA, RNA, or protein. Nitazoxanide has been shown to be effective against persistent strains of influenza A (H1N1) and A (H3N2) as well as rotavirus. It also has been shown to have a low toxicity profile in human clinical trials. Nitazoxanide is not an anti-inflammatory agent and does not inhibit cyclooxygenase enzymes. The drug can potentially be used for treatment of cancer due to its ability to inhibit mitochondrial membrane potential, which may lead to cell death.Formula:C12H9N3O5SPurity:Min. 98 Area-%Color and Shape:White Slightly Yellow PowderMolecular weight:307.28 g/mol
